Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

13

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

13 results for “Yellow fever virus”

Learn how ShareScore rates datasets ↗
zenodo40/100

Genomic epidemiology unveils the dynamics and spatial corridor behind the Yellow Fever virus outbreak in Southern Brazil

<p>Despite the considerable morbidity and mortality of yellow fever virus (YFV) infections in Brazil our understanding of disease outbreaks is hampered by limited viral genomic data. Determining the timing and spatial corridors of YFV spread, as well as the geographic hotspots that link the endemic north of the country with epidemic extra-Amazonian regions, are central to predicting and preventing future outbreak and epidemics. Here, we tracked the recent spread of the virus by integrating genome sequences with both epidemiological and vector data. Through a combination of phylogenetic and epidemiological models we reconstructed the recent transmission history of YFV within different epidemic seasons in Brazil. A suitability index based on the highly domesticated <em>Aedes aegypti</em> was able to capture the seasonality of reported human infections. Spatial modelling revealed spatial hotspots with both past reporting and low vaccination coverage, which coincided with many of the largest urban centres in the Southeast. Phylodynamic analysis unravelled the circulation of three distinct YFV lineages, and provided proof of the directionality of a known spatial corridor of viral spread that connects the endemic North with the extra-Amazonian basin. This study illustrates that genomics linked with eco-epidemiology in a One Health framework can provide new insights into the landscape of YFV transmission, augmenting traditional approaches to infectious disease surveillance and control.</p>

opencc-by-4.0Jun 2023View details →
dryad32/100

Data from: Screening test for neutralizing antibodies against yellow fever virus, based on a flavivirus pseudotype

Given the possibility of yellow fever virus reintroduction in epidemiologically receptive geographic areas, the risk of vaccine supply disruption is a serious issue. New strategies to reduce the doses of injected vaccines should be evaluated very carefully in terms of immunogenicity. The plaque reduction test for the determination of neutralizing antibodies (PRNT) is particularly time-consuming and requires the use of a confinement laboratory. We have developed a new test based on the use of a non-infectious pseudovirus (WN/YF17D). The presence of a reporter gene allows sensitive determination of neutralizing antibodies by flow cytometry. This WN/YF17D test was as sensitive as PRNT for the follow-up of yellow fever vaccinees. Both tests lacked specificity with sera from patients hospitalized for acute Dengue virus infection. Conversely, both assays were strictly negative in adults never exposed to flavivirus infection or vaccination, and in patients sampled some time after acute Dengue infection. This WN/YF17D test will be particularly useful for large epidemiological studies and for screening for neutralizing antibodies against yellow fever virus.

opencc-zeroDec 2016View details →
ClinicalTrials.gov32/100

Safety and Tolerability of an Antibody Against Yellow Fever Virus (TY014) in Humans

ClinicalTrials.gov study NCT03776786. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Yellow Fever Virus Vaccine and Immune Globulin Study

ClinicalTrials.gov study NCT00254826. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
dryad32/100

Data from: Screening test for neutralizing antibodies against yellow fever virus, based on a flavivirus pseudotype

Open the record for dataset details and reuse information.

publicMay 2018View details →
ClinicalTrials.gov28/100

Trial of an Inactivated Yellow Fever Virus Vaccine

ClinicalTrials.gov study NCT05172544. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
geo24/100

Whole genome DNA methylation analysis of human CD8 T cell specific for the Yellow fever virus vaccine

GEO Series GSE75533. Homo sapiens. 4 samples. Type: Methylation profiling by high throughput sequencing.

openGEO-OpenDec 2017View details →
geo24/100

CRISPR screen for interferon-alpha inducible inhibitors of yellow fever virus replication

GEO Series GSE121710. Homo sapiens. 2 samples. Type: Other.

openGEO-OpenOct 2018View details →
geo24/100

Mitochondrial Hyperactivity and Reactive Oxygen Species Drive Innate Immunity to the Yellow Fever Virus-17D Live-Attenuated Vaccine

GEO Series GSE293880. Homo sapiens. 36 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenApr 2025View details →
ClinicalTrials.gov24/100

Characterization of T Cell Responses Following Yellow Fever Virus Vaccination in Healthy Adults

ClinicalTrials.gov study NCT00616356. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
geo24/100

Integrative biology of patients acutely infected with yellow fever virus

GEO Series GSE243442. Homo sapiens. 55 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenDec 2024View details →
geo20/100

The yellow fever virus capsid protein is a potent suppressor of RNA silencing that binds double stranded RNA.

GEO Series GSE80691. Aedes aegypti. 6 samples. Type: Non-coding RNA profiling by high throughput sequencing.

openGEO-OpenJan 2017View details →
geo12/100

External RNA Control Consortium (ERCC) spikes in RNA sequencing (RNA-Seq) data normalization: transcriptome analysis of yellow fever virus-infected cells

GEO Series GSE99081. Homo sapiens. 24 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenMay 2020View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record